Literature DB >> 30768788

Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition.

M Napolitano1, M Megna2, G Fabbrocini2, S P Nisticò3, N Balato2, S Dastoli3, C Patruno3.   

Abstract

Entities:  

Year:  2019        PMID： 30768788     DOI： 10.1111/bjd.17779

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

Review 1.  Eczematous Drug Eruptions.

Authors:  Amy E Blum; Susan Burgin
Journal:  Am J Clin Dermatol       Date:  2021-02-15       Impact factor: 7.403

2.  Eczematous eruption after guselkumab treatment for psoriasis.

Authors:  Birgit Reyn; Tom Hillary; Ann Gils
Journal:  JAAD Case Rep       Date:  2019-10-24

Review 3.  The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside.

Authors:  Taoming Liu; Sheng Li; Shuni Ying; Shunli Tang; Yuwei Ding; Yali Li; Jianjun Qiao; Hong Fang
Journal:  Front Immunol       Date:  2020-11-17       Impact factor: 7.561

4.  Paradoxical eczema in patients with psoriasis receiving biologics: a case series.

Authors:  Ali Al-Janabi; Amy Charlotte Foulkes; Christopher Ernest Maitland Griffiths; Richard Bruce Warren
Journal:  Clin Exp Dermatol       Date:  2022-03-10       Impact factor: 4.481

Review 5.  Pathogenesis of Paradoxical Reactions Associated with Targeted Biologic Agents for Inflammatory Skin Diseases.

Authors:  Fumi Miyagawa
Journal:  Biomedicines       Date:  2022-06-23

6.  Onset of vitiligo in a psoriasis patient on ixekizumab.

Authors:  Claudio Marasca; Luigi Fornaro; Fabrizio Martora; Vincenzo Picone; Gabriella Fabbrocini; Matteo Megna
Journal:  Dermatol Ther       Date:  2021-09-02       Impact factor: 3.858

7.  Risankizumab treatment in psoriasis patients who failed anti-IL17: A 52-week real-life study.

Authors:  Matteo Megna; Luca Potestio; Angelo Ruggiero; Elisa Camela; Gabriella Fabbrocini
Journal:  Dermatol Ther       Date:  2022-04-26       Impact factor: 3.858

Review 8.  From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment.

Authors:  Silvia Vidal; Lluís Puig; José-Manuel Carrascosa-Carrillo; Álvaro González-Cantero; José-Carlos Ruiz-Carrascosa; Antonio-Manuel Velasco-Pastor
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.